Vertex Pharmaceuticals Incorporated Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Best And Worst Performing S&P 500 Stocks In 2017
Article By: Bespoke Investment Group
Friday, December 29, 2017 7:07 PM EST
While the cap-weighted S&P 500 gained 19.42% on the year, the average stock in the index was up less than that at just over 18%. There were exactly 50 stocks in the S&P that gained more than 50% on the year, and only 3 that gained more than 100%.
In this article: BA, NRG, ALGN, AMZN, NFLX, VRTX, FB
Read
5 Hot Stocks Driving The Nasdaq ETF Rally
Article By: Sweta Killa
Tuesday, December 19, 2017 12:30 PM EST
The Nasdaq Composite Index gained 0.8% on the day, outperforming the other two benchmarks, the S&P 500 and Dow Jones, and hit the major milestone of 7,000 for the first time.
In this article: ALGN, MELI, MU, VRTX, WYNN Also: QQQ
Read
4 Of The Most Efficient Stocks To Buy Now
Article By: Zacks Investment Research
Saturday, October 21, 2017 9:38 AM EST
Companies with favorable efficiency levels are likely to be on investors’ radar irrespective of market conditions.
In this article: VRTX, LULU, SAFM, FMAO
Read
5 Pharma & Biotech Stocks That Could Be Big Winners In Q3 Earnings
Article By: Arpita Dutt
Tuesday, October 10, 2017 4:34 PM EST
Pharma and biotech stocks started 2017 on a strong note with this part of the market remaining in favor as the year progresses. So far this year, the Nasdaq Biotechnology Index is up 25.6%.
In this article: LLY, MRK, PFE, BIIB, VRTX Also: NVS, GILD
Read
Forget Teva, Buy These 5 Drug Stocks Instead
Article By: Arpita Dutt
Monday, October 9, 2017 1:43 PM EST
While Teva deals with these challenges, I have selected five drug companies that look well-positioned.
In this article: PFE, LGND, AMGN, CELG, VRTX Also: MYL, TEVA
Read

PARTNER HEADLINES

Latest Tweets for $VRTX

No tweets yet!